KLEIN JOSEPH III sold 51.1% of their position (11.52K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $910.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+11.52K
Price / share
$39.94
Trade value
$460.03K
% of position
Common Stock
Shares
−99.00
Price / share
$79.45
Trade value
$7.87K
% of position
Common Stock
Shares
−11.42K
Price / share
$79.04
Trade value
$902.55K
% of position
Net shares
+0.00
Net value
-$450.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | M · Option Exercise | +11.52K | $39.94 | $460.03K | 104.6% | 11.01K | 22.53K |
| Common Stock Direct | 7/1/2026 | S · Sale | −99.00 | $79.45 | $7.87K | 0.4% | 22.53K | 22.43K |
| Common Stock Direct | 7/1/2026 | S · Sale | −11.42K | $79.04 | $902.55K | 50.9% | 22.43K | 11.01K |
| Total | +0.00 | -$450.39K | ||||||
Non-Qualified Stock Option (right to buy)
Common Stock
11.52K shares
Shares
−11.52K
Strike price
39.94
Held after
0.00
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
5.37K shares
Shares
+5.37K
Strike price
79.19
Held after
5.37K
Exercisable
—
Restricted Stock Unit
Common Stock
2.30K shares
Shares
+2.30K
Strike price
0.0
Held after
16.28K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock11.52K shares | 7/1/2026 | M · Option Exercise | −11.52K | 39.94 | — | 0.00 |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock5.37K shares | 7/1/2026 | A · Award | +5.37K | 79.19 | — | 5.37K |
| Restricted Stock Unit Direct | Common Stock2.30K shares | 7/1/2026 | A · Award | +2.30K | 0.0 | — | 16.28K |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 200.00 | Indirect |
| Total | 200.00 | 200.00 indirect |